1. Home
  2. AMPH vs BFS Comparison

AMPH vs BFS Comparison

Compare AMPH & BFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Amphastar Pharmaceuticals Inc.

AMPH

Amphastar Pharmaceuticals Inc.

N/A

Current Price

$28.85

Market Cap

1.1B

Sector

Health Care

ML Signal

N/A

Logo Saul Centers Inc.

BFS

Saul Centers Inc.

N/A

Current Price

$28.40

Market Cap

902.2M

Sector

Real Estate

ML Signal

N/A

Company Overview

Basic Information
Metric
AMPH
BFS
Founded
1996
1993
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Real Estate Investment Trusts
Sector
Health Care
Real Estate
Exchange
Nasdaq
Nasdaq
Market Cap
1.1B
902.2M
IPO Year
2005
1996

Fundamental Metrics

Financial Performance
Metric
AMPH
BFS
Price
$28.85
$28.40
Analyst Decision
Hold
Strong Buy
Analyst Count
7
2
Target Price
$24.50
★ $42.00
AVG Volume (30 Days)
★ 415.9K
118.1K
Earning Date
11-05-2026
11-05-2026
Dividend Yield
N/A
★ 8.26%
EPS Growth
N/A
★ N/A
EPS
★ 1.67
0.78
Revenue
★ $719,887,000.00
$289,843,000.00
Revenue This Year
$3.81
$7.69
Revenue Next Year
$4.91
$3.08
P/E Ratio
★ $17.10
$36.57
Revenue Growth
N/A
★ 7.81
52 Week Low
$16.65
$28.13
52 Week High
$31.00
$38.42

Technical Indicators

Market Signals
Indicator
AMPH
BFS
Relative Strength Index (RSI) 64.24 37.90
Support Level $27.24 N/A
Resistance Level $29.35 $35.04
Average True Range (ATR) 1.07 0.65
MACD 0.15 0.01
Stochastic Oscillator 61.97 17.07

Price Performance

Historical Comparison
AMPH
BFS

About AMPH Amphastar Pharmaceuticals Inc.

Amphastar Pharmaceuticals Inc is a bio-pharmaceutical company focusing on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products, as well as insulin active pharmaceutical ingredient (or insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has one reportable segment: pharmaceutical products. Geographically, the business presence of the firm is seen in the United States, China, and France, of which the U.S. accounts for the majority of the revenue.

About BFS Saul Centers Inc.

Saul Centers Inc is a self-managed real estate investment trust which invests in, operates and develops retail and commercial properties. The company's portfolio includes community and neighbourhood shopping centres, office properties, and mixed-use properties. Properties are located in the Washington, D.C. and Batlimore metropolitan areas. Saul Centers operates through two business segments: Shopping Centers segment, which contribute the maximum portion of total revenue; and mixed-use properties.Mixed-Use Properties segment include office, retail and multi-family residential use.

Share on Social Networks: